Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NOVARTIS

  • FDA Approval
  • Sept. 14, 2023, 20:27 UTC
  • 36
  • 0 comments

FDA approve CARBAMAZEPINE

Comment Full text

NOVARTIS

  • FDA Approval
  • Sept. 14, 2023, 20:27 UTC
  • 31
  • 0 comments

FDA approve CARBAMAZEPINE

Comment Full text

CIPLA

  • FDA Approval
  • Sept. 14, 2023, 11:45 UTC
  • 26
  • 0 comments

FDA approve DIHYDROERGOTAMINE MESYLATE

Comment Full text

CURIUM

  • FDA Approval
  • Sept. 14, 2023, 11:45 UTC
  • 29
  • 0 comments

FDA approve IOFLUPANE I-123

Comment Full text

MICRO LABS

  • FDA Approval
  • Sept. 14, 2023, 11:45 UTC
  • 32
  • 0 comments

FDA approve PIRFENIDONE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Sept. 14, 2023, 11:45 UTC
  • 30
  • 0 comments

FDA approve HYDROXYCHLOROQUINE SULFATE

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • Sept. 14, 2023, 11:45 UTC
  • 28
  • 0 comments

FDA approve MESALAMINE

Comment Full text

CIPLA

  • FDA Approval
  • Sept. 14, 2023, 11:45 UTC
  • 29
  • 0 comments

FDA approve ISOPROTERENOL HYDROCHLORIDE

Comment Full text

EYWA

  • FDA Approval
  • Sept. 14, 2023, 11:45 UTC
  • 30
  • 0 comments

FDA approve METHYLPHENIDATE HYDROCHLORIDE

Comment Full text

SCINOPHARM TAIWAN

  • FDA Approval
  • Sept. 14, 2023, 11:45 UTC
  • 35
  • 0 comments

FDA approve FONDAPARINUX SODIUM

Comment Full text
  • Previous
  • 677
  • 678
  • 679
  • 680
  • 681
  • Next

Search

News categories

  • Technical Exchange News(11991)
  • Event(5170)
  • SEC News(249025)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(149675)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin